Brazil Angioplasty Devices Market Report 2026

Market Size in 2025: USD 279.8 Million

Market Size in 2026: USD 293.6 Million

Market Forecast in 2034: USD 431.2 Million

Market Growth Rate: 4.92% (2026-2034)

According to a recent study by IMARC Group Research Report, titled “Brazil Angioplasty Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026-2034,” the Brazil angioplasty devices market grew from USD 279.8 Million in 2025 to USD 293.6 Million in 2026. Looking forward, the market is expected to reach USD 431.2 Million by 2034, exhibiting a CAGR of 4.92% during 2026-2034.

Download a sample PDF of this report: https://www.imarcgroup.com/brazil-angioplasty-devices-market/requestsample

Brazil Angioplasty Devices Industry Trends and Demands in 2026:

Brazil’s angioplasty devices market in 2026 is being driven by the high and rising burden of cardiovascular disease across the population. Coronary artery disease remains a leading cause of mortality in Brazil, underpinning consistent demand for percutaneous coronary intervention procedures and the stents, guidewires, and balloon catheters that support them. Expanding healthcare coverage, government hospital investment programs, and gradual improvement in access to specialist cardiac care outside major urban centers are broadening the patient population receiving interventional cardiology procedures.

Technological advancement in device design is a key market trend, with drug-eluting stents and bioresorbable scaffolds gaining adoption at the expense of bare-metal stents across Brazil’s leading cardiology centers. Peripheral angioplasty is also growing as Brazil’s vascular surgeons address the high prevalence of peripheral artery disease linked to diabetes and obesity. Local manufacturing is gaining strategic importance as Brazil’s health technology sector seeks to reduce import dependence, while public-private partnerships in hospital infrastructure are expanding the capacity of specialty clinics to perform angioplasty procedures across the country.

How AI is Reshaping the Future of the Brazil Angioplasty Devices Market

• AI is improving clinical outcomes in angioplasty procedures performed in Brazil by supporting imaging analysis, lesion assessment, and procedural planning. AI algorithms integrated with intravascular imaging systems can rapidly characterize plaque composition, assess stenosis severity, and recommend optimal device selection for individual patient anatomy. This reduces procedural variability, supports less experienced interventional cardiologists in making sound clinical decisions, and improves stent sizing accuracy. As Brazil expands angioplasty capacity into regional hospitals and specialty clinics, AI decision support tools are increasingly valuable for maintaining quality outcomes outside major academic cardiac centers.
• AI-driven predictive analytics are supporting patient risk stratification and post-procedure monitoring in Brazil’s cardiology system. Machine learning models analyze patient demographics, comorbidities, biomarkers, and procedure data to identify individuals at higher risk for in-stent restenosis, major adverse cardiac events, or readmission following angioplasty. This enables cardiologists to tailor follow-up protocols, adjust medication regimens, and prioritize higher-risk patients for more intensive surveillance. As Brazil’s public health system works to improve long-term outcomes in cardiovascular care, AI-based population health management tools are becoming an important complement to procedural innovation.
• AI is accelerating design innovation in angioplasty devices by enabling manufacturers to simulate device behavior in virtual coronary artery models with complex anatomies. Computational fluid dynamics powered by AI allow engineers to optimize stent strut geometry, balloon inflation characteristics, and guidewire flexibility profiles to improve deliverability and reduce vascular trauma. For companies serving Brazil’s market, AI-assisted design iteration reduces the time and cost of bringing next-generation devices through regulatory clearance, supporting a continuous pipeline of product improvements that meet evolving clinical standards and physician preferences.

Brazil Angioplasty Devices Market Segmentation:

The market report offers a comprehensive analysis of the segments, highlighting those with the largest Brazil angioplasty devices market share. It includes forecasts for the period 2026-2034 and historical data from 2020-2025 for the following segments.

Product Type Insights:

• Stents
• Guidewires
• Balloons
• Others

Application Insights:

• Coronary Angioplasty
• Peripheral Angioplasty

End User Insights:

• Hospitals
• Specialty Clinics
• Others

Regional Insights:

• Southeast
• South
• Northeast
• North
• Central-West

Competitive Landscape:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Additionally, the report features detailed profiles of all major companies in the Brazil angioplasty devices industry.

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic plc
• Terumo Corporation
• B. Braun Melsungen AG

Recent News and Developments in Brazil Angioplasty Devices Market

March 2026: Leading medical device companies expanded their Brazil commercial and distribution networks, aiming to improve availability of advanced drug-eluting stent and guidewire systems in regional hospitals and specialty cardiology centers.

June 2026: Brazil’s regulatory authority approved several next-generation angioplasty device submissions, clearing the path for wider adoption of improved balloon catheter and bioresorbable scaffold technologies across the country’s interventional cardiology centers.

Ongoing: Rising prevalence of cardiovascular disease, expanding hospital capacity, growing adoption of advanced stent technologies, and improving healthcare coverage continue to drive steady growth in Brazil’s angioplasty devices market.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302